These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8450605)

  • 41. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Altomonte V; Hess AD; Santos GW
    Blood; 1992 Jun; 79(11):3031-5. PubMed ID: 1586747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
    Hess AD; Jones RC; Santos GW
    Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.
    Fefer A; Sullivan KM; Weiden P; Buckner CD; Schoch G; Storb R; Thomas ED
    Prog Clin Biol Res; 1987; 244():401-8. PubMed ID: 3310002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice.
    Singhal S; Vourka-Karussis U; Mehta J; Slavin S; Weiss L
    Leuk Res; 1996; 20(11-12):941-6. PubMed ID: 9009252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Santos GW
    Leuk Lymphoma; 1993 Oct; 11(3-4):215-20. PubMed ID: 8260896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 49. Autologous graft-versus-host disease: a new frontier in immunotherapy.
    Hess AD; Jones RJ; Morris LE; Noga SJ; Yeager AM; Vogelsang GB; Santos GW
    Bone Marrow Transplant; 1992; 10 Suppl 1():16-21. PubMed ID: 1521086
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].
    Jung G; Holler E; Kolb HJ; Wilmanns W
    Internist (Berl); 1989 Jun; 30(6):386-8. PubMed ID: 2503460
    [No Abstract]   [Full Text] [Related]  

  • 51. Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation.
    Ratanatharathorn V; Uberti J; Karanes C; Lum LG; Abella E; Dan ME; Hussein M; Sensenbrenner LL
    Bone Marrow Transplant; 1994 May; 13(5):625-30. PubMed ID: 8054915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
    Darmstadt GL; Donnenberg AD; Vogelsang GB; Farmer ER; Horn TD
    J Invest Dermatol; 1992 Oct; 99(4):397-402. PubMed ID: 1401996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic graft-versus-host reaction following bone marrow transplantation].
    Ippen H; Nagel G
    Hautarzt; 1984 Apr; 35(4):182-7. PubMed ID: 6373672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
    Kennedy MJ; Vogelsang GB; Beveridge RA; Farmer ER; Altomonte V; Huelskamp AM; Davidson NE
    J Clin Oncol; 1993 Mar; 11(3):478-84. PubMed ID: 8445424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
    Kennedy MJ; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Altomonte V; Huelskamp AM; Davidson NE
    J Clin Oncol; 1994 Feb; 12(2):249-57. PubMed ID: 8113833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.
    Hess AD; Jones RJ; Morris LE; Noga SJ; Vogelsang GB; Santos GW
    Hum Immunol; 1992 Jul; 34(3):219-24. PubMed ID: 1429045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic bone marrow transplatation in a patient with Shwachman-Diamond syndrome.
    Arseniev L; Diedrich H; Link H
    Ann Hematol; 1996 Feb; 72(2):83-4. PubMed ID: 8597612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
    Horn TD; Altomonte V; Vogelsang G; Kennedy MJ
    J Am Acad Dermatol; 1996 Mar; 34(3):413-7. PubMed ID: 8609251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
    Spaner D; Lowsky R; Fyles G; Lipton JH; Banerjee D; Ng CM; Wade JA; Messner HA
    Transplantation; 1998 Nov; 66(9):1251-3. PubMed ID: 9825825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
    Kennedy MJ; Jones RJ
    Breast Cancer Res Treat; 1993; 26 Suppl():S31-40. PubMed ID: 8400331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.